Showing results (221-230 of 378) with videos related to

Sort By:
Pageof 38
ESMO Open|January 5, 2021
How we treat endocrine complications of immune checkpoint inhibitorsS A Paschou, K Stefanaki, T Psaltopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expressionA Psyrri, P Kountourakis, A Scorilas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Prognostic role of serum beta 2-microglobulin in Hodgkin's diseaseM A Dimopoulos, F Cabanillas, J J Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapyE Terpos, E Kastritis, D Christoulas, et al.
European Journal of Gynaecological Oncology|August 27, 2005
Late relapse of epithelial ovarian cancer: a single institution experienceA Bamias, E Efstathiou, M Vassilakopoulou, et al.
European Journal of Gynaecological Oncology|January 10, 2006
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterusG T Bozas, A Bamias, E Kastritis, et al.
Gynecologic Oncology|June 30, 2000
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter studyM A Dimopoulos, C A Papadimitriou, V Georgoulias, et al.
Pageof 38